Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Korean Center for Disease Control and Prevention | OTHER_GOV |
| Pfizer | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Our objective of this study is to derive a real incidence of CDI in tertiary hospitals located through Korean peninsula. In order to get a close value to the truth, the study is planned to co-perform with a national study which was proposed in evaluation process to include more hospitals. Along with the incidence of CDI, clinical characteristics and outcome of CDI will be examined and microbiologic characteristics of C. difficile isolates from CDI patients are studied.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| incidence of CDI | Incidence of CDI among hospitalized adults per 100,000 patient*days/10,000 patient*admission in enrolled tertiary hospitals. | through Oct 2020 to Dec 2021 |
| Measure | Description | Time Frame |
|---|---|---|
| mortality rate | Proportion of CDI cases who died during the 60-day follow-up period | through Oct 2020 to May 2022 |
| recurrence rate | Proportion of CDI cases with recurrence/reinfection between Day 14 and Day 60 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
The patients who admitted at the tertiary hospitals in Korea and and diagnosed as Clostridioides difficile infection will be selected.
The tertiary hospitals located in Seoul-si, Gyeonggi-do, Pusan-si, Daegu-si, Jeollanam-do, Jeollabuk-do, and Chungcheongbuk-do. These hospitals distributes all over the country.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Hyunjoo Pai, M.D., Ph.D. | Contact | +82-2-2290-8356 | paihyunjoo@gmail.com | |
| Jieun Kim, M.D., Ph.D. | Contact | +82-31-560-2249 | quidam76@hanyang.ac.kr |
| Name | Affiliation | Role |
|---|---|---|
| Hyunjoo Pai, M.D., Ph.D. | Hanyang University | Study Chair |
Not provided
Not provided
| ID | Term |
|---|---|
| D003015 | Clostridium Infections |
| ID | Term |
|---|---|
| D016908 | Gram-Positive Bacterial Infections |
| D001424 | Bacterial Infections |
| D001423 | Bacterial Infections and Mycoses |
| D007239 | Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
C. difficile isolates
| through Oct 2020 to May 2022 |